Thrombopoietin Receptor Agonist Mitigates Hematopoietic Radiation Syndrome and Improves Survival after Whole-Body Ionizing Irradiation Followed by Wound Trauma
about
Combined Therapy of Pegylated G-CSF and Alxn4100TPO Improves Survival and Mitigates Acute Radiation Syndrome after Whole-Body Ionizing Irradiation alone and Followed by Wound Trauma.Hemorrhage enhances cytokine, complement component 3, and caspase-3, and regulates microRNAs associated with intestinal damage after whole-body gamma-irradiation in combined injury.
P2860
Thrombopoietin Receptor Agonist Mitigates Hematopoietic Radiation Syndrome and Improves Survival after Whole-Body Ionizing Irradiation Followed by Wound Trauma
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Thrombopoietin Receptor Agonis ...... ation Followed by Wound Trauma
@ast
Thrombopoietin Receptor Agonis ...... ation Followed by Wound Trauma
@en
type
label
Thrombopoietin Receptor Agonis ...... ation Followed by Wound Trauma
@ast
Thrombopoietin Receptor Agonis ...... ation Followed by Wound Trauma
@en
prefLabel
Thrombopoietin Receptor Agonis ...... ation Followed by Wound Trauma
@ast
Thrombopoietin Receptor Agonis ...... ation Followed by Wound Trauma
@en
P2093
P2860
P50
P356
P1476
Thrombopoietin Receptor Agonis ...... ation Followed by Wound Trauma
@en
P2093
Pei-Jun Liao
Thomas B Elliott
P2860
P304
P356
10.1155/2017/7582079
P577
2017-03-20T00:00:00Z